Chief Executive Officer of Recce Pharmaceuticals. “There is a demand for new antibiotic therapies, and this report further showcases R327’s potential as a novel treatment for a broad range of ...

Following the raise, Recce will have a pro-forma cash position of $16m. This excludes an R&D rebate expected from the ATO in ...

Recce Pharmaceuticals (ASX:RCE) said it had received a notice of acceptance from the China National Intellectual Property ...

Intelligence agencies report that terrorists conducted recce of three areas in Pahalgam on April 15th, including an amusement park, before choosing Bayasaran Valley for the attack. The terrorists ...

We think intelligent long term investing is the way to go. But that doesn't mean long term investors can avoid ...

Recce Pharmaceuticals Ltd., a player in the biotech and medtech sector, has issued a presentation emphasizing the risks and uncertainties associated with its future plans and strategies. Investors ...

Pratik Shah, reportedly, was part of the recce in London for the biopic of Sourav Ganguly. The film's team will now search ...

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today announced ...

Follows recently released positive Phase II clinical trial data of R327G for acute bacterial skin and skin-structure infections Special Report ... anti-infectives Recce Pharmaceuticals has ...

Recce receives firm commitments to place the ... raise Recce will have a pro-forma cash balance of $16 million Special Report: Developer of a new class of synthetic anti-infectives, Recce ...